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The increased diversion and non-medical use of prescribed medications has raised 
concerns internationally and in Australia (DCPC 2007). The harms associated with non-
medical prescription drug use, notably dependence and overdose, are well-documented 
(Loxley 2007; McGregor et al. 2002). However, the links between illicit drug use, including 
illicit or non-medical prescription drug use, and crime are less clear. While illicit drug use is 
substantially higher in offender populations compared with the general community (Adams 
et al. 2008; AIHW 2008), direct causal links between specific drugs, including prescription 
drugs, and specific offences have not been clearly identified (McKetin et al. 2006). Marked 
changes in illicit drug use patterns in recent years include a decrease in heroin use and an 
increase in non-medical prescription drug use (Black et al. 2008; DCPC 2007; Zarocostas 
2009).
In Australia, the most commonly diverted pharmaceuticals for illicit use are benzodiazepines 
and opioids (Dobbin 1998). The rise in non-medical pharmaceutical opioid use is thought  
to be in response to the decrease in heroin availability that began around the end of 2000. 
Despite this problem, objective information on the extent of the diversion and non-medical 
use of pharmaceuticals in Australia is sparse. A number of methods are used to gain  
access to prescribed medications including presenting inaccurate symptoms to health 
professionals, consulting with multiple doctors, poor prescribing practices by medical 
practitioners, self-prescribing by health practitioners, theft of the medication from surgeries 
or pharmacies, altering and forging prescriptions, and purchasing over the internet (DCPC 
2007). A focus group study and review of illicit pharmaceutical markets in the United States 
identified the diversity of sources of illicit pharmaceuticals including drug tourism, direct 
purchases on the street and in nightclubs, and theft from elderly relatives (Inciardi et al. 
2007). According to this review, prescription drugs are common targets of residential 
burglaries and home invasions. 
Foreword  |  Concern regarding the 
diversion and non-medical use of 
prescription pharmaceuticals continues 
to grow as anecdotal evidence and other 
research points to a sizeable increase  
in the illegal market for such drugs. 
Estimating the prevalence of illegal use 
and understanding how pharmaceutical 
drugs come to be traded in the illegal 
drug market remain key research 
priorities for policymakers and 
practitioners in both the public health 
and law enforcement sectors. 
This report is the first of its kind in 
Australia to examine the self-reported 
use of illicit pharmaceuticals among  
a sample of police detainees surveyed  
as part of the Australian Institute of 
Criminology’s Drug Use Monitoring in 
Australia (DUMA) program. In all, 986 
detainees were interviewed, of which  
19 percent reported having recently used 
pharmaceutical drugs for non-medical 
purposes in the past 12 months—nearly 
five times as high as reported by the 
general Australian population, once again 
highlighting the value of conducting drug 
use research among criminal justice 
populations. In addition, this paper 
provides policymakers with valuable 
information about the reasons for  
use and the methods by which 
pharmaceuticals are typically accessed 
for non-medical purposes.
Adam Tomison 
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ascertain the main methods of obtaining 
access to these medications.
The prescription drug use addendum was 
developed as a collaborative effort between 
Edith Cowan University and the Australian 
Institute of Criminology and was piloted  
at three sites in the fourth quarter of 2008. 
Questions were developed to examine  
the types of pharmaceuticals used, the 
frequency of use, the methods of obtaining 
pharmaceuticals and the reasons for 
non-medical use of prescribed drugs. 
Identifying appropriate terminology was 
particularly challenging as it was necessary 
for the respondent to recognise the 
difference between appropriate medical  
use and use that was not intended by  
the prescribing doctor even when the 
medication had been legally obtained. The 
full addendum was administered nationally 
in the first quarter collection period of 2009. 
Eight sites—Footscray, Kings Cross, 
Bankstown, Adelaide City, East Perth, 
Brisbane City, Southport and Darwin—
participated in the study. A total of 1,614 
detainees completed the core DUMA 
questionnaire in the first quarter 2009.  
Of these, 986 (61%) also completed the 
addendum. This group of 986 detainees 
comprised the study sample. All references 
to prescribed drug use in this report refer to 
non-medical use.
of investigating the extent of non-medical 
prescription drug use among detainees. 
They planned to use the data to describe 
current trends in the illegal possession of 
legal drugs from a police perspective, with 
an aim to clarify and develop the role of 
policing in this area. This report presents  
the results of the DUMA prescription drugs 
addendum developed in response to these 
concerns.
Methodology
The DUMA program is designed to collect 
demographic, lifetime and current 
substance use history and criminal justice-
related information on a quarterly basis from 
those recently detained by the police (see 
Makkai 1999 for a full explanation of the 
project methodology). Self-reported drug 
use is validated by the collection of a urine 
sample. The core DUMA questionnaire has 
remained consistent over time, allowing for 
year-by-year comparisons. The study design 
also allows for the inclusion of a one to two 
page addendum on key topical issues each 
quarter. The prescription drugs addendum 
was included in the DUMA data collection 
during the first quarter of 2009 and was 
designed to assess the prevalence of 
non-medical prescription drug use among 
police detainees. Secondary aims were to 
assess differences between users and 
non-users of prescription drugs and to 
The major source of information on 
prescription drug use in the Australian 
community is the National Drug Strategy 
Household Survey, a triennial survey that 
measures drug use trends in a random 
sample of Australian households. The 2007 
National Drug Strategy Household Survey 
surveyed over 23,000 households and 
found that after cannabis (9%), non-medical 
pharmaceutical use (4%) was the most 
common illicit drug use category reported 
for the previous 12 months (AIHW 2008). 
Painkillers/analgesics (3%) followed by 
tranquillisers/sleeping pills (1%) were the 
most common types of pharmaceuticals 
used. Over half (53%) of those who had 
recently (in the previous 12 months) used 
painkillers most frequently obtained them 
from a shop or retail outlet, while recent 
users of tranquillisers most commonly 
nominated a ‘friend or acquaintance’ as 
their source of supply (40%). A national 
study of injecting drug users in Australia 
(n=909) showed that for 18 percent of the 
sample, morphine was the pharmaceutical 
opioid injected most often in the month  
prior to interview. Ten percent had injected 
pharmaceutical stimulants, including 
dexamphetamine and methylphenidate, and 
nine percent had injected benzodiazepines 
in the previous six months (Black et al. 2008).
There are few studies of non-medical 
prescription drug use by offenders. The 
Drug Use Monitoring in Australia (DUMA) 
study of drug use among police detainees 
showed that during 2008, around one-
quarter of benzodiazepine users reported 
non-medical benzodiazepine use in the 
previous 30 days. Non-medical use of  
the pharmaceutical opioid methadone  
was identified in 28 percent of detainees 
testing positive for methadone, while 
non-medical use of the pharmaceutical 
opioid buprenorphine was identified in  
36 percent of detainees testing positive  
for buprenorphine (Gaffney et al. 2010).
Prompted by an apparent increase in the 
availability of pharmaceuticals in illicit drug 
markets identified by police seizures and  
an increase in detainees in the watch  
house having prescription medicine in their 
possession, WA Police approached the WA 
DUMA project group to develop a method 
Figure 1 Prescription drug use by site (%)
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the highest prevalence of opioid use (see 
Figure 1). It should be noted however that 
sample sizes for these sites were relatively 
small.
Across all sites, of those detainees  
who reported prescription drug use, 
benzodiazepines (n=124; 65%) were  
the type most commonly used in the 
previous 12 months (see Table 2).
Of the benzodiazepines, diazepam was 
used by two-fifths and alprazolam by 
around one-quarter of pharmaceutical 
users. The next most commonly used type 
was opioids, used by over one-third (n=70; 
37%) of prescribed drug users in the 
previous 12 months (more than 1 opioid 
could be nominated).
Other drug types such as antipsychotics 
and antidepressants were used by less  
than 10 percent of detainees who had 
reported pharmaceutical use in the  
previous 12 months.
Sample characteristics
Prescription drug users were more likely 
than non-users to be unemployed, derive 
their income from welfare or benefits, 
consider themselves drug dependent, be 
currently on a drug-related charge and have 
been arrested or imprisoned in the previous 
12 months (see Table 3).
Of the 190 detainees who reported 
prescription drug use in the previous  
12 months, 26 (14%) used daily, 53 (28%) 
used once a week or more, 28 (15%) used 
monthly, 28 (15%) used every few months 
and 54 (29%) used once or twice a year  
(1 missing case).
Females were significantly more likely than 
males to have used prescription drugs for 
non-medical purposes. Over one-quarter 
(27%) of females in the sample had taken 
pharmaceuticals for non-medical purposes 
in the previous 12 months compared to  
18 percent of males (χ2=6.97, df 1, p=.008).
Reasons
Qualitative analysis of the reasons given  
for using pharmaceuticals identified five 
themes. The most common reason for  
use was for the relief of negative emotional 
states such as anxiety and for the relief of 
Results
Of the 986 respondents who completed the 
addendum, almost one in five detainees 
(19%) reported non-medical prescription 
drug use in the previous 12 months. 
Proportionally, Footscray, Kings Cross, 
Adelaide City and Brisbane City sites had 
the highest prevalence of non-medical 
prescription drug use. Prevalence at the 
East Perth, Southport and Bankstown sites 
was between 10 and 20 percent, while  
in Darwin the prevalence was less than  
10 percent (see Table 1).
A breakdown of drug types by site shows 
that proportionally, Footscray had the 
highest prevalence of benzodiazepine use, 
markedly higher than the site with the next 
highest prevalence, Kings Cross which had 
Table 1 Prescription drug use by site
PDUa n(%) No PDU n(%) Total (n)
Footscray 18(35) 34(65) 52
Kings Cross 13(28) 34(72) 47
Adelaide 31(24) 101(77) 132
Brisbane 45(22) 161(78) 206
East Perth 40(19) 176(82) 216
Southport 23(18) 133(85) 156
Bankstown 14(16) 73(84) 87
Darwin 6(7) 84(93) 90
Total 190(19) 796(81) 986
a: Prescription drug use
Table 2 Type of pharmaceuticals taken in the previous 12 months 
Pharmaceutical na %b
Benzodiazepines
Diazepam (eg Valium, Ducene) 76 40.0
Alprazolam (eg Xanax, Kalma) 47 24.7
Oxazepam (eg Serepax, Murelax) 17 8.9
Temazepam (eg Normison, Temaze) 8 4.2
Other benzodiazepine 7 3.7
Nitrazepam (eg Mogadon, Alodorm) 5 2.6
Clonazepam (eg Klonopin) 5 2.6
Flunitrazepam (eg Rohypnol) 3 1.6
Opioids
Morphine 35 18.4
Unspecified opioids 24 12.6
Buprenorphine (eg Subutex) 12 6.3
Methadone 10 5.3
Codeine 6 3.2
Other pharmaceuticals
Miscellaneous 17 8.9
Antipsychotics 16 8.4
Dexamphetamine 14 7.4
Antidepressants 2 1.1
Hallucinogens 1 0.5
a: More than 1 substance could be nominated
b:  Base is those who used prescription drugs in the previous  
2 months less 1 missing case (n=189)
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Only five respondents provided information 
on the number of different pharmacies used. 
These respondents nominated between two 
and 10 pharmacies, while one respondent 
went to over 20 pharmacies to have their 
scripts filled.
Other sources of scripts
Only two respondents had obtained a script 
that was not from a doctor; one had forged 
their own script, the other had taken it from 
a doctor’s surgery. Of these, one respondent 
had the script filled at their usual pharmacy 
and the other had gone to a different 
pharmacy.
Scripts written in someone else’s 
name
Of those who had used prescription drugs 
in the previous 12 months, 20 (11%) had 
obtained them using a script written in 
someone else’s name. Of these, 19 
respondents had used a script written for a 
friend or family member. One respondent 
had borrowed a Medicare card, one had 
bought it from a pharmaceutical dealer and 
one had bought a Medicare card. No 
respondents had stolen a Medicare card.
Of the 20 respondents who had obtained 
prescription drugs using a script written in 
someone else’s name, information on where 
the scripts were filled was provided by 19 
respondents. Nine (47%) got someone else 
to go to a pharmacy to fill the script, seven 
(37%) went to their usual pharmacy and 
three (16%) went to a different pharmacy 
each time to fill the script.
Other ways of obtaining 
pharmaceuticals
Of the 189 detainees who provided 
information on their prescription drug use, 
45 (24%) had bought them from a dealer,  
48 (25%) had bought them from a friend or 
family member, 82 (43%) had been given 
them by a friend or family member and  
13 (7%) had swapped them for another 
drug. Five detainees indicated other ways  
of obtaining pharmaceuticals. Two obtained 
them from strangers, one from a laboratory 
at work, one from a chemist in Thailand and 
one obtained them in jail. No respondent 
had purchased them over the internet.
meth/amphetamine as having been used  
in combination with pharmaceuticals in the 
previous 12 months.
Scripts obtained from doctors
Of the 189 pharmaceutical users who 
provided data, 39 (21%) had used a script  
in their own name written by a doctor to 
obtain prescription drugs. Of these 39 
respondents, the majority (n=26; 67%) 
obtained the script from their usual doctor, 
eight (21%) went to a new doctor and five 
(13%) went to a different doctor each time. 
This latter group went to between three and 
six different doctors each time. One-third 
(n=13; 33%) had deliberately provided 
inaccurate information to obtain a script.
Of these 39 respondents, 38 provided 
information on where they usually got their 
scripts filled. The majority (n=31; 82%) went 
to their usual pharmacy; the remaining 
seven (18%) respondents went to a different 
pharmacy to have their scripts filled.
insomnia (41%). Over one-quarter of those 
who had taken pharmaceuticals in the 
previous 12 months did so for their positive 
effects such as getting ‘high’ (30%). 
Managing drug withdrawal symptoms  
or drug substitution was nominated by  
16 percent, while eight percent cited 
curiosity or because the drugs were 
available. Pain relief was cited by  
five percent of respondents.
Drugs used in combination  
with pharmaceuticals
Of the 190 detainees who had taken 
pharmaceuticals for non-medical purposes 
in the previous 12 months, 134 (71%)  
had used them in combination with other 
substances (see Table 4).
Alcohol was the most common substance 
combined with pharmaceuticals; combined 
use was nominated by over half of users. 
Cannabis was nominated by almost 
one-third and heroin by over one-quarter. 
Around one-fifth (21%) nominated  
Table 3 Sample characteristics
No PDU (n=796) PDU (n=190) Total sample (n=986)
Age, median years (range) 28(16–79) 27(16–55)* 28(16–79)
Currently in a relationship n(%) 241(30) 50(26) 291(30)
Completed year 10 or less n(%) 360(45) 99(52) 459(47)
Unemployed n(%) 431(54) 145(76)*** 410(42)
Income from welfare/benefits n(%) 393(49) 137(73)*** 530(54)
Drug dependent n(%) 249(36) 133(70)*** 382(39)a
Currently on drugs-related charge n(%) 85(11) 34(18)** 119(12)
Times arrested in past year, median (range) 2(1–80) 4(1–100)*** 3(1–100)
In prison in past year n(%) 132(17) 61(33)*** 193(20)
a: n=880
*p < .05; **p < .01; ***p < .001
Table 4 Drug used in combination with pharmaceuticals
Drug combined with PD na %
Alcohol 77 57.5
Cannabis 41 30.6
Heroin 38 28.4
Methamphetamine 15 11.2
Amphetamines 13 9.7
Methadone 7 5.2
Morphine 4 3.0
Cocaine 2 1.5
MDMA 0 0.0
a: More than one drug could be nominated
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prescription drug use, including that of 
antipsychotics and antidepressants, 
probably reflects the lack of reinforcing 
properties of these drugs as they do not 
produce marked stimulating or sedative 
effects.
Prescription drug use was higher in women, 
younger people, the unemployed and 
detainees who considered themselves  
drug dependent. Use was also associated 
with indicators of social disadvantage and 
offending behaviour. Specifically, more users 
had a current drugs-related charge, had 
been arrested in the previous 12 months 
and had been in prison in the previous  
12 months. Prescription drug use appeared 
to have a specific purpose or function for 
most of the detainees using them. While a 
minority took pharmaceuticals for reasons  
of curiosity or availability, most took them to 
relieve negative emotional states, insomnia, 
pain or symptoms associated with drug 
dependence. Additionally, over one-quarter 
had taken prescription drugs for their 
reinforcing or hedonic properties.
In summary, non-medical prescription drug 
use was found to be substantially higher  
in the detainee population by comparison 
with the general community. Among the 
detainees surveyed, more prescription  
drug users were unemployed, derived their 
income from welfare or benefits, considered 
themselves drug dependent, were currently 
on a drug-related charge and had been 
arrested or imprisoned in the previous  
12 months by comparison with non-users. 
Most pharmaceuticals were sourced from 
family and friends or from the person’s usual 
doctor and pharmacy. There was little 
support for the view that pharmaceuticals 
are commonly obtained through script 
forgery or over the internet. Benzodiazepines, 
followed by opioids, were the most 
commonly used pharmaceuticals for 
non-medical purposes in this sample  
of police detainees. Further research to 
investigate the methods of obtaining illicit 
pharmaceuticals from within the general 
community is needed.
Relationship between 
pharmaceutical use  
and offence categories
The 16 Australian Standard Offence 
Classification (ASOC) offence divisions  
were combined to construct four offence 
groupings (ABS 2008). ASOC Divisions 1, 2, 
3, 5 and 6 were designated offences against 
the person. Divisions 7, 8, 9 and 12 were 
designated property offences. The single 
division number 10 (illicit drug offences)  
was designated illicit drug offences and the 
remaining divisions (4, 11, 13, 14, 15, and 
16) were amalgamated into an other group. 
The four offence groupings were tested  
in a logistic regression model in which  
the effects of age and gender could be 
controlled. This analysis found that two 
offence groupings, property offences 
(p=.241) and other offences (p=.223) did not 
predict prescription drug use in the previous 
12 months. The model showed that after 
controlling for age and gender, the odds  
of being charged with an offence against  
the person were significantly lower for 
pharmaceutical users by comparison  
with non-pharmaceutical users (p=.027).
The odds of being charged with an illicit 
drug offence were 80 percent greater for 
prescribed drug users by comparison with 
non-users. Being female was a significant 
predictor of prescribed drug use, as was 
age. The odds of reporting prescription  
drug use were over 70 percent greater  
in detainees under 30 years of age by 
comparison with those over 30 years 
(p=.001).
Relationship between 
benzodiazepine use  
and illicit drug use
Benzodiazepines were the most common 
pharmaceutical used by the detainees 
surveyed. To provide more objective 
evidence of potential illicit drug 
combinations with benzodiazepines,  
a subgroup comprising detainees who 
completed the addendum and additionally 
provided a urine sample, was extracted 
from the larger sample. A total of 767 
individual cases were available for analysis. 
Results showed that there was no 
relationship between having a positive 
MDMA urine test and benzodiazepine  
use in the previous 12 months; however, 
significantly more of those detainees who 
tested positive for amphetamines reported 
benzodiazepine use in the previous  
12 months (20% cf 11%). Overall, heroin 
use had the strongest association with 
benzodiazepine use. Almost one-third (32%) 
of detainees with a positive urine test for 
heroin also reported benzodiazepine use 
compared with 10 percent of those with a 
negative urine test for heroin. These results 
support the view that benzodiazepines are 
commonly used to counter the unwanted 
effects of amphetamines as well as 
managing withdrawal symptoms. 
Benzodiazepines are also used to manage 
the symptoms of heroin withdrawal and  
to mimic the sedative effects of heroin.
Discussion
The prevalence of non-medical prescription 
drug use in the previous 12 months (19%) 
was markedly higher among police 
detainees in comparison to the general 
community (4%; AIHW 2008). Across DUMA 
sites, the prevalence of prescription drug 
use was highest in the large metropolitan 
areas and lowest in Darwin. Consistent  
with other studies (Dobbin 1998), 
benzodiazepines followed by opioids were 
the most commonly used pharmaceuticals 
for non-medical purposes. Heroin users 
(confirmed by urinalysis) had the highest 
prevalence of benzodiazepine use among 
the sample.
Diazepam, followed by alprazolam, were  
the benzodiazepines used most frequently 
by prescription drug users. This pattern  
may reflect their availability at low cost  
on the pharmaceutical benefits scheme.  
In 2007, diazepam and alprazolam were 
respectively the most frequently dispensed 
benzodiazepines through the 
pharmaceutical benefits scheme (DUSCS 
2009). The relatively low use of 
flunitrazepam in this sample may reflect the 
difficulty of accessing this benzodiazepine 
since its rescheduling to an S8 drug in 
1998. Of the opioids, morphine was most 
commonly used by prescription drug users 
in this sample. This again is consistent with 
other studies of Australian users (Dobbin 
1998). The low prevalence of other 
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